Intriguingly, levels of the SCFA propionate, a potent endogenous agonist of FFA2, are elevated following RYGB in rodents
Intriguingly, a phase 2B clinical trial of tirzepatide in people with diabetes and obesity suggested that this analogue, at the highest doses tested, has superior effects on glycaemia in comparison to the benchmark GLP-1 analogue dulaglutide (reductions in HbA1c of 1.9% vs
If your body can't tolerate one GLP-1 drug, you may be able to try another
For optimal results, consistency is key
Twice daily (morning + evening): Best for active hair growth goals, hair loss prevention, or if youre using a moderate concentration (25%) and your scalp tolerates it well